Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04738825 · ClinicalTrials.gov registry record · NA
Promoting HIV Risk Reduction Among People Who Inject Drugs: A Stepped Care Approach Using Contingency Management With PrEP Adherence and Support Services
A NA study of Opioid Use Disorder and HIV Prevention Program, sponsored by Yale University.
- Recruiting
- Registry status
- NA
- Development phase
- 526
- Enrollment target
- 6
- Study locations
NCT04738825 is a NA study of Opioid Use Disorder and HIV Prevention Program that is actively recruiting participants, run by Yale University. The registered enrollment target is 526 participants, below the 4,654-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (89% lower). The trial reports 6 study locations across 2 states.
The verdict
NCT04738825, a NA study of Opioid Use Disorder and HIV Prevention Program, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- NA
- Development phase
- 526 participants
- Enrollment target
- 6
- Study locations
Study Summary
The proposed study will be a 24-week intervention with a 12-month follow-up period to evaluate the impact of contingency management with stepped care to pre-exposure prophylaxis (PrEP) adherence and support services (CoMPASS) to promote HIV prevention among individuals with opioid use disorder who have injected drugs in their lifetime. In parallel, the investigators will conduct an implementation focused process evaluation to inform real-world implementation of CoMPASS. .
Conditions Studied
Interventions
- BEHAVIORAL Contingency Management with stepped care to PrEP adherence and support services (CoMPASS)
Study Locations (6)
Connecticut
- Recovery Network of Programs, Inc - Bridgeport
- Liberations Program, Inc - Bridgeport
- Apex Community Care. Inc. - Danbury
- Greater Hartford Harm Reduction Coalition- SWAN - New Haven
- APT - New Haven
Massachusetts
- Stanley Street Treatment and Resource Center - Fall River
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 526 participants |
| Start Date | 2021-10-04 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04738825
The ClinicalTrials.gov registry entry for NCT04738825 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 526 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,654-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (89% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Opioid Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which Contingency Management with stepped care to PrEP adherence and support services (CoMPASS) is the first listed.
NCT04738825 reports 6 study locations spanning 2 distinct geographic areas - top geographies include Connecticut, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04738825 about?
NCT04738825 is a clinical study titled "Promoting HIV Risk Reduction Among People Who Inject Drugs: A Stepped Care Approach Using Contingency Management With PrEP Adherence and Support Services". The proposed study will be a 24-week intervention with a 12-month follow-up period to evaluate the impact of contingency management with stepped care to pre-exposure prophylaxis (PrEP) adherence and support services (CoMPASS) to promote HIV prevention among individuals with opioid use disorder who h...
What is the current status of trial NCT04738825?
This trial is currently recruiting. It is a NA study. The enrollment target is 526 participants. The study started on 2021-10-04. Estimated completion is 2026-06-30.
What conditions does trial NCT04738825 study?
This clinical trial studies the following conditions: Opioid Use Disorder, HIV Prevention Program.
What interventions are being tested in trial NCT04738825?
The interventions under investigation include: Contingency Management with stepped care to PrEP adherence and support services (CoMPASS) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04738825?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04738825 being conducted?
This trial has 6 study locations across Connecticut, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Sustaining Recovery for People on Opioid Agonist Treatment With Conversational Agents
RECRUITING · NA
-
Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for MOUD
RECRUITING · NA
-
Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail
RECRUITING · NA
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
Using Facebook to Support Opioid Recovery Among American Indian Women
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.